Rise and fall of glycoprotein IIb-IIIa inhibitors in ST-segment elevation myocardial infarction

被引：5
|
作者：
Di Mario, Carlo [1 ,2 ]
机构：
[1] Royal Brompton Hosp, NIHR Cardiovasc BRU, Dept Cardiol, London SW3 6NP, England
[2] NHLI Imperial Coll, London SW3 6NP, England
来源：
HEART | 2014年 / 100卷 / 11期
关键词：
MYOCARDIAL ISCHAEMIA AND INFARCTION (IHD); PERCUTANEOUS CORONARY INTERVENTION; STANDARD THERAPY; DOUBLE-BLIND; TRIAL; CLOPIDOGREL; FIBRINOLYSIS; ANGIOPLASTY; ABCIXIMAB;
D O I：
10.1136/heartjnl-2013-305374
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：823 / 824
页数：2
相关论文
共 50 条
  • [1] Administration of glycoprotein IIb-IIIa inhibitors in patients with ST-segment elevation myocardial infarction
    Dobesh, PP
    Kasiar, JB
    [J]. PHARMACOTHERAPY, 2002, 22 (07): : 864 - 888
  • [2] Glycoprotein IIb/IIIa inhibitors: Therapeutic applications in acute ST-segment elevation myocardial infarction
    Campbell, KR
    Cantor, W
    Sketch, M
    Ohman, EM
    [J]. AMERICAN HEART JOURNAL, 2000, 140 (06) : S115 - S124
  • [3] Upstream Treatment of ST-Segment Elevation Myocardial Infarction: The Role of Glycoprotein IIb/IIIa Inhibitors
    Joyal, Dominique
    Eisenberg, Mark J.
    [J]. CANADIAN JOURNAL OF CARDIOLOGY, 2011, 27 (05) : 534 - 535
  • [4] Glycoprotein IIb/IIIa inhibitors in acute ST segment elevation myocardial infarction
    Holper, EM
    Giugliano, RP
    Antman, EM
    [J]. CORONARY ARTERY DISEASE, 1999, 10 (08) : 567 - 573
  • [5] Glycoprotein IIb/IIIa receptor inhibitors versus bivalirudin in patients with ST-segment elevation myocardial infarction
    Angeras, Oskar
    Ioanes, Dan
    Ramunddal, Truls
    Omerovic, Elmir
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (18) : B82 - B82
  • [6] Glycoprotein IIb/IIIa inhibition in the setting of acute ST-segment elevation myocardial infarction
    Eisenberg, MJ
    Jamal, S
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 42 (01) : 1 - 6
  • [7] Glycoprotein IIb/IIIa Inhibitor (Tirofiban) in Acute ST-Segment Elevation Myocardial Infarction
    Fang, Ching-Chang
    Jao, Yeun Tarl Fresner Ng
    Chen, Yi
    Yu, Ching-Lung
    Wang, Shih-Pu
    [J]. ANGIOLOGY, 2009, 60 (02) : 192 - 200
  • [8] Pexelizumab may be hazardous to those with ST-segment elevation myocardial infarction undergoing primary percutaneous interventions without using glycoprotein IIb-IIIa inhibitors
    Lin, Gen-Min
    Chu, Kai-Min
    Han, Chih-Lu
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2011, 146 (02) : 280 - 282
  • [9] Is Still There a Place for Glycoprotein IIb-IIIa Inhibitors in Modern Treatment of ST-Elevation Myocardial Infarction?
    Jorge, Elisabete
    Baptista, Rui
    Teixeira, Rogerio
    Saraiva, Fatima
    Mendes, Paulo
    Lourenco, Carolina
    Goncalves, Francisco
    Monteiro, Pedro
    Freitas, Mario
    Providencia, La
    [J]. CIRCULATION, 2010, 122 (02) : E249 - E249
  • [10] Glycoprotein IIb/IIIa Receptor Inhibitors in Patients with ST-Segment Elevation Myocardial Infarction and Primary Percutaneous Coronary Intervention
    Tereshchenko, Andrey S.
    Merkulov, Evgeny, V
    Samko, Anatoly N.
    [J]. RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2019, 15 (06) : 918 - 927
12345